Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) EBIT (2016 - 2025)

Geron (GERN) has disclosed EBIT for 16 consecutive years, with -$25.5 million as the latest value for Q4 2025.

  • Quarterly EBIT fell 27.38% to -$25.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$68.6 million through Dec 2025, up 60.52% year-over-year, with the annual reading at -$68.6 million for FY2025, 60.52% up from the prior year.
  • EBIT hit -$25.5 million in Q4 2025 for Geron, down from -$13.9 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$12.5 million in Q2 2025 to a low of -$69.3 million in Q2 2024.
  • Historically, EBIT has averaged -$34.4 million across 5 years, with a median of -$28.8 million in 2021.
  • Biggest five-year swings in EBIT: plummeted 85.7% in 2023 and later surged 82.04% in 2025.
  • Year by year, EBIT stood at -$31.0 million in 2021, then plummeted by 35.4% to -$42.0 million in 2022, then fell by 29.41% to -$54.3 million in 2023, then skyrocketed by 63.07% to -$20.0 million in 2024, then dropped by 27.38% to -$25.5 million in 2025.
  • Business Quant data shows EBIT for GERN at -$25.5 million in Q4 2025, -$13.9 million in Q3 2025, and -$12.5 million in Q2 2025.